Plain-English translation of NCT05218356 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2 clinical trial testing a medication called Codivir in people hospitalized with moderate COVID-19. You would receive either the medication or a placebo (a dummy injection with no active drug) twice daily for 7 days, along with your regular hospital care. Researchers want to see if this treatment helps people with COVID-19 recover better.
COVID-19 can cause serious breathing problems that require hospitalization, and doctors are looking for additional treatments beyond standard care that might help patients recover faster and more completely.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either Codivir or a placebo injection twice daily for up to 7 days. If you improve quickly, you may go home to continue injections with nurse visits twice a day, or you may stay hospitalized depending on your condition. Either way, you'll be contacted by phone or video call regularly through day 28 to check on your symptoms and any side effects.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Brazil